Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Health

A New Red Line

Newsletter

Sign up for our email newsletter for the latest science news

After cancer has spread its tentacles through the body, a cure can be almost as bad as the disease. High-dose chemotherapy can kill roaming tumor cells, but it also takes out the vital "stem cells" in the bone marrow that make blood. A marrow transplant can replenish these cells, but it leaves the patient exposed to attack by foreign immune cells in the grafted tissue. What the body desperately needs is a way to regenerate itself.

Stephen Bartelmez and Tsvee Lapidot are searching for a way to take a small sample of stem cells from a patient before chemotherapy, grow the cells into a large population, and then return them to rebuild the bone marrow. Bartelmez, an immunologist at the Seattle Biomedical Research Institute, just successfully cultured stem cells from mice. Shortly after, Lapidot, a hematologist at the Weizmann Institute of Science in Rehovot, Israel, performed the same feat with human cells.

The next challenge was to increase the numbers of cells. Bartelmez nourished the mouse cells with a hormone that enabled him to increase their number by a millionfold. Lapidot enhanced his human stem cells by engineering them to respond more vigorously to the chemical messengers that spur cells to divide. "Until now, we were barely able to keep stem cells alive much less multiply their number," says a buoyant Bartelmez. "This discovery will now enable certain cancer treatments-such as for severe breast, lung, and colon cancers-to become realistically successful."

2 Free Articles Left

Want it all? Get unlimited access when you subscribe.

Subscribe

Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 70%

Subscribe

Already a subscriber? Register or Log In